
GlaxoSmithKline remained under pressure today after so-so results that drew unfavourable comparisons with US rival Pfizer.
The drug giant notched up £1.4 billion of Covid-19 related sales last year, yet profits still fell 22% to £5.4 billion. Overall sales were steady at £34 billion.